MedTrace Logo

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

NCT00398645 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 648

Last updated 2018-01-23

No results posted yet for this study

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

Conditions

Interventions

DRUG

GW685698X 200mcg,GW685698X 200mcg and 400mcg

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-15
Primary Completion
2007-08-01
Completion
2007-08-30

Countries

  • United States
  • Australia
  • Bulgaria
  • Canada
  • Chile
  • Croatia
  • Germany
  • Israel
  • Mexico
  • New Zealand
  • Peru
  • Philippines
  • Russia
  • South Africa
  • Thailand
  • Ukraine

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00398645 on ClinicalTrials.gov